VIAF

Virtual International Authority File

Search

Leader 00000nz a2200037n 45 0
001 WKP|Q42888837 (VIAF cluster) (Authority/Source Record)
003 WKP
005 20241121000043.0
008 241121nneanz||abbn n and d
035 ‎‡a (WKP)Q42888837‏
024 ‎‡a 0000-0001-7236-264X‏ ‎‡2 orcid‏
035 ‎‡a (OCoLC)Q42888837‏
100 0 ‎‡a Robert Baatenburg De Jong‏ ‎‡9 ast‏ ‎‡9 es‏ ‎‡9 sl‏
375 ‎‡a 1‏ ‎‡2 iso5218‏
400 0 ‎‡a Robert Baatenburg De Jong‏ ‎‡c researcher‏ ‎‡9 en‏
400 0 ‎‡a Robert Baatenburg De Jong‏ ‎‡c onderzoeker‏ ‎‡9 nl‏
670 ‎‡a Author's A beneficial tumor microenvironment in oropharyngeal squamous cell carcinoma is characterized by a high T cell and low IL-17(+) cell frequency‏
670 ‎‡a Author's Absent and abundant MET immunoreactivity is associated with poor prognosis of patients with oral and oropharyngeal squamous cell carcinoma‏
670 ‎‡a Author's Cancer stem cell enrichment marker CD98: a prognostic factor for survival in patients with human papillomavirus-positive oropharyngeal cancer‏
670 ‎‡a Author's Clinical outcome of T1 glottic carcinoma since the introduction of endoscopic CO2 laser surgery as treatment option‏
670 ‎‡a Author's Comorbidity as a major risk factor for mortality and complications in head and neck surgery‏
670 ‎‡a Author's Compliance and efficiency before and after implementation of a clinical practice guideline for laryngeal carcinomas‏
670 ‎‡a Author's Conditional relative survival in head and neck squamous cell carcinoma: Permanent excess mortality risk for long-term survivors‏
670 ‎‡a Author's Cytology and histology have limited added value in prognostic models for salivary gland carcinomas‏
670 ‎‡a Author's Detection of oral squamous cell carcinoma and cervical lymph node metastasis using activatable near-infrared fluorescence agents.‏
670 ‎‡a Author's Differences in cancer gene copy number alterations between Epstein-Barr virus-positive and Epstein-Barr virus-negative nasopharyngeal carcinoma‏
670 ‎‡a Author's Discrimination between oral cancer and healthy tissue based on water content determined by Raman spectroscopy‏
670 ‎‡a Author's DNA ploidy status as a prognostic marker and predictor of lymph node metastasis in laryngeal carcinoma‏
670 ‎‡a Author's Dual wavelength tumor targeting for detection of hypopharyngeal cancer using near-infrared optical imaging in an animal model‏
670 ‎‡a Author's Effects of transforming growth factor-β subtypes on in vitro cartilage production and mineralization of human bone marrow stromal-derived mesenchymal stem cells‏
670 ‎‡a Author's Evaluating adherence to the Dutch guideline for diagnosis, treatment and follow-up of laryngeal carcinomas‏
670 ‎‡a Author's Experience of palliative care for patients with head and neck cancer through the eyes of next of kin: impact of an Expert Center‏
670 ‎‡a Author's Fibroblast Growth Factor Receptors in In Vitro and In Vivo Chondrogenesis: Relating Tissue Engineering Using Adult Mesenchymal Stem Cells to Embryonic Development‏
670 ‎‡a Author's Hypofractionated radiotherapy denoted as the "Christie scheme": an effective means of palliating patients with head and neck cancers not suitable for curative treatment‏
670 ‎‡a Author's Illness cognitions in head and neck squamous cell carcinoma: predicting quality of life outcome‏
670 ‎‡a Author's Image-guided surgery in head and neck cancer: current practice and future directions of optical imaging.‏
670 ‎‡a Author's Impact of comorbidity on short-term mortality and overall survival of head and neck cancer patients‏
670 ‎‡a Author's Incidence and prediction of major cardiovascular complications in head and neck surgery‏
670 ‎‡a Author's Increasing prevalence rates of HPV attributable oropharyngeal squamous cell carcinomas in the Netherlands as assessed by a validated test algorithm.‏
670 ‎‡a Author's Influence of previous tumours on survival in early‏
670 ‎‡a Author's Influence of previous tumours on survival in early (Tis-T1) glottic carcinoma‏
670 ‎‡a Author's Investigation of the potential of Raman spectroscopy for oral cancer detection in surgical margins‏
670 ‎‡a Author's Markers for Nodal Metastasis in Head and Neck Squamous Cell Cancer‏
670 ‎‡a Author's Model-assisted predictions on prognosis in HNSCC: do we learn?‏
670 ‎‡a Author's Molecular characterization of p16-immunopositive but HPV DNA-negative oropharyngeal carcinomas.‏
670 ‎‡a Author's Molecular profile of nasopharyngeal carcinoma: analysing tumour suppressor gene promoter hypermethylation by multiplex ligation-dependent probe amplification‏
670 ‎‡a Author's Neonatal head ultrasonography today: a powerful imaging tool!‏
670 ‎‡a Author's No evidence for active human papillomavirus‏
670 ‎‡a Author's No evidence for active human papillomavirus (HPV) in fields surrounding HPV-positive oropharyngeal tumors‏
670 ‎‡a Author's Noncompliance to guidelines in head and neck cancer treatment; associated factors for both patient and physician.‏
670 ‎‡a Author's Novel Contrast-Enhanced Ultrasound Evaluation in Neonatal Hypoxic Ischemic Injury: Clinical Application and Future Directions.‏
670 ‎‡a Author's Novel diagnostic modalities for assessment of the clinically node-negative neck in oral squamous-cell carcinoma‏
670 ‎‡a Author's Novel head and neck cancer survival analysis approach: random survival forests versus Cox proportional hazards regression‏
670 ‎‡a Author's Optical image-guided cancer surgery: challenges and limitations‏
670 ‎‡a Author's Optical imaging of oral squamous cell carcinoma and cervical lymph node metastasis‏
670 ‎‡a Author's Outcome of radiotherapy in T1 glottic carcinoma: a population-based study‏
670 ‎‡a Author's Parathyroid hormone related protein and interleukin-6 mRNA expression in larynx and renal cell carcinomas from normocalcaemic and hypercalcaemic patients.‏
670 ‎‡a Author's Partial remission of parotid gland carcinoma after goserelin‏
670 ‎‡a Author's Prediction of survival with alternative modeling techniques using pseudo values‏
670 ‎‡a Author's Prognosis: A variable parameter. Dynamic prognostic modeling in head and neck squamous cell carcinoma‏
670 ‎‡a Author's Prognostic index for patients with parotid carcinoma‏
670 ‎‡a Author's Psychosocial consequences for partners of patients after total laryngectomy and for the relationship between patients and partners‏
670 ‎‡a Author's Quality of life and illness perceptions in patients with recently diagnosed head and neck cancer.‏
670 ‎‡a Author's Quality of life and voice outcome of patients treated with transoral CO laser microsurgery for early glottic carcinoma‏
670 ‎‡a Author's Quality of life and voice outcome of patients treated with transoral CO laser microsurgery for early glottic carcinoma (T1-T2): a 2-year follow-up study‏
670 ‎‡a Author's Raman spectroscopic analysis of the molecular composition of oral cavity squamous cell carcinoma and healthy tongue tissue‏
670 ‎‡a Author's Resection margins in oral cancer surgery: Room for improvement.‏
670 ‎‡a Author's Role of Epstein-Barr virus DNA measurement in plasma in the clinical management of nasopharyngeal carcinoma in a low risk area.‏
670 ‎‡a Author's Second malignant neoplasia in early‏
670 ‎‡a Author's Second malignant neoplasia in early (TIS-T1) glottic carcinoma‏
670 ‎‡a Author's Survival of patients with palliative head and neck cancer.‏
670 ‎‡a Author's Targeting integrins and enhanced permeability and retention‏
670 ‎‡a Author's Targeting integrins and enhanced permeability and retention (EPR) effect for optical imaging of oral cancer‏
670 ‎‡a Author's The eHealth self-management application 'Oncokompas' that supports cancer survivors to improve health-related quality of life and reduce symptoms: which groups benefit most?‏
670 ‎‡a Author's Treatments and costs for recurrent and/or metastatic squamous cell carcinoma of the head and neck in the Netherlands‏
670 ‎‡a Author's Update and external validation of a head and neck cancer prognostic model‏
670 ‎‡a Author's Utility approach to decision-making in extended T1 and limited T2 glottic carcinoma‏
670 ‎‡a Author's Validation of a gene expression signature for assessment of lymph node metastasis in oral squamous cell carcinoma.‏
670 ‎‡a Author's Variation in Integrated Head and Neck Cancer Care: Impact of Patient and Hospital Characteristics‏
670 ‎‡a Author's Voice outcome after unilateral ELS type III or bilateral type II resections for T1-T2 glottic carcinoma: Results after 1 year‏
670 ‎‡a Author's Voice outcome in T1a midcord glottic carcinoma: laser surgery vs radiotherapy‏
670 ‎‡a Author's Voice profile after type I or II laser chordectomies for T1a glottic carcinoma‏
670 ‎‡a Author's Zenker's diverticulum: Rotterdam experience.‏
909 ‎‡a (orcid) 000000017236264x‏ ‎‡9 1‏
919 ‎‡a voiceoutcomeint1amidcordglotticcarcinomalasersurgeryvsradiotherapy‏ ‎‡A Voice outcome in T1a midcord glottic carcinoma: laser surgery vs radiotherapy‏ ‎‡9 1‏
919 ‎‡a voiceprofileaftertype1or2laserchordectomiesfort1aglotticcarcinoma‏ ‎‡A Voice profile after type I or II laser chordectomies for T1a glottic carcinoma‏ ‎‡9 1‏
919 ‎‡a zenkersdiverticulumrotterdamexperience‏ ‎‡A Zenker's diverticulum: Rotterdam experience.‏ ‎‡9 1‏
919 ‎‡a qualityoflifeandvoiceoutcomeofpatientstreatedwithtransoralcolasermicrosurgeryforearlyglotticcarcinoma‏ ‎‡A Quality of life and voice outcome of patients treated with transoral CO laser microsurgery for early glottic carcinoma‏ ‎‡9 1‏
919 ‎‡a qualityoflifeandillnessperceptionsinpatientswithrecentlydiagnosedheadandneckcancer‏ ‎‡A Quality of life and illness perceptions in patients with recently diagnosed head and neck cancer.‏ ‎‡9 1‏
919 ‎‡a psychosocialconsequencesforpartnersofpatientsaftertotallaryngectomyandfortherelationshipbetweenpatientsandpartners‏ ‎‡A Psychosocial consequences for partners of patients after total laryngectomy and for the relationship between patients and partners‏ ‎‡9 1‏
919 ‎‡a prognosticindexforpatientswithparotidcarcinoma‏ ‎‡A Prognostic index for patients with parotid carcinoma‏ ‎‡9 1‏
919 ‎‡a prognosisavariableparameterdynamicprognosticmodelinginheadandnecksquamouscellcarcinoma‏ ‎‡A Prognosis: A variable parameter. Dynamic prognostic modeling in head and neck squamous cell carcinoma‏ ‎‡9 1‏
919 ‎‡a predictionofsurvivalwithalternativemodelingtechniquesusingpseudovalues‏ ‎‡A Prediction of survival with alternative modeling techniques using pseudo values‏ ‎‡9 1‏
919 ‎‡a partialremissionofparotidglandcarcinomaaftergoserelin‏ ‎‡A Partial remission of parotid gland carcinoma after goserelin‏ ‎‡9 1‏
919 ‎‡a parathyroidhormonerelatedproteinandinterleukin6mrnaexpressioninlarynxandrenalcellcarcinomasfromnormocalcaemicandhypercalcaemicpatients‏ ‎‡A Parathyroid hormone related protein and interleukin-6 mRNA expression in larynx and renal cell carcinomas from normocalcaemic and hypercalcaemic patients.‏ ‎‡9 1‏
919 ‎‡a outcomeofradiotherapyint1glotticcarcinomaapopulationbasedstudy‏ ‎‡A Outcome of radiotherapy in T1 glottic carcinoma: a population-based study‏ ‎‡9 1‏
919 ‎‡a opticalimagingoforalsquamouscellcarcinomaandcervicallymphnodemetastasis‏ ‎‡A Optical imaging of oral squamous cell carcinoma and cervical lymph node metastasis‏ ‎‡9 1‏
919 ‎‡a opticalimageguidedcancersurgerychallengesandlimitations‏ ‎‡A Optical image-guided cancer surgery: challenges and limitations‏ ‎‡9 1‏
919 ‎‡a novelheadandneckcancersurvivalanalysisapproachrandomsurvivalforestsversuscoxproportionalhazardsregression‏ ‎‡A Novel head and neck cancer survival analysis approach: random survival forests versus Cox proportional hazards regression‏ ‎‡9 1‏
919 ‎‡a noveldiagnosticmodalitiesforassessmentoftheclinicallynodenegativeneckinoralsquamouscellcarcinoma‏ ‎‡A Novel diagnostic modalities for assessment of the clinically node-negative neck in oral squamous-cell carcinoma‏ ‎‡9 1‏
919 ‎‡a novelcontrastenhancedultrasoundevaluationinneonatalhypoxicischemicinjuryclinicalapplicationandfuturedirections‏ ‎‡A Novel Contrast-Enhanced Ultrasound Evaluation in Neonatal Hypoxic Ischemic Injury: Clinical Application and Future Directions.‏ ‎‡9 1‏
919 ‎‡a noncompliancetoguidelinesinheadandneckcancertreatmentassociatedfactorsforbothpatientandphysician‏ ‎‡A Noncompliance to guidelines in head and neck cancer treatment; associated factors for both patient and physician.‏ ‎‡9 1‏
919 ‎‡a noevidenceforactivehumanpapillomavirushpvinfieldssurroundinghpvpositiveoropharyngealtumors‏ ‎‡A No evidence for active human papillomavirus (HPV) in fields surrounding HPV-positive oropharyngeal tumors‏ ‎‡9 1‏
919 ‎‡a noevidenceforactivehumanpapillomavirus‏ ‎‡A No evidence for active human papillomavirus‏ ‎‡9 1‏
919 ‎‡a neonatalheadultrasonographytodayapowerfulimagingtool‏ ‎‡A Neonatal head ultrasonography today: a powerful imaging tool!‏ ‎‡9 1‏
919 ‎‡a molecularprofileofnasopharyngealcarcinomaanalysingtumoursuppressorgenepromoterhypermethylationbymultiplexligationdependentprobeamplification‏ ‎‡A Molecular profile of nasopharyngeal carcinoma: analysing tumour suppressor gene promoter hypermethylation by multiplex ligation-dependent probe amplification‏ ‎‡9 1‏
919 ‎‡a molecularcharacterizationofp16immunopositivebuthpvdnanegativeoropharyngealcarcinomas‏ ‎‡A Molecular characterization of p16-immunopositive but HPV DNA-negative oropharyngeal carcinomas.‏ ‎‡9 1‏
919 ‎‡a modelassistedpredictionsonprognosisinhnsccdowelearn‏ ‎‡A Model-assisted predictions on prognosis in HNSCC: do we learn?‏ ‎‡9 1‏
919 ‎‡a markersfornodalmetastasisinheadandnecksquamouscellcancer‏ ‎‡A Markers for Nodal Metastasis in Head and Neck Squamous Cell Cancer‏ ‎‡9 1‏
919 ‎‡a investigationofthepotentialoframanspectroscopyfororalcancerdetectioninsurgicalmargins‏ ‎‡A Investigation of the potential of Raman spectroscopy for oral cancer detection in surgical margins‏ ‎‡9 1‏
919 ‎‡a influenceofprevioustumoursonsurvivalinearlytist1glotticcarcinoma‏ ‎‡A Influence of previous tumours on survival in early (Tis-T1) glottic carcinoma‏ ‎‡9 1‏
919 ‎‡a influenceofprevioustumoursonsurvivalinearly‏ ‎‡A Influence of previous tumours on survival in early‏ ‎‡9 1‏
919 ‎‡a increasingprevalenceratesofhpvattributableoropharyngealsquamouscellcarcinomasinthenetherlandsasassessedbyavalidatedtestalgorithm‏ ‎‡A Increasing prevalence rates of HPV attributable oropharyngeal squamous cell carcinomas in the Netherlands as assessed by a validated test algorithm.‏ ‎‡9 1‏
919 ‎‡a incidenceandpredictionofmajorcardiovascularcomplicationsinheadandnecksurgery‏ ‎‡A Incidence and prediction of major cardiovascular complications in head and neck surgery‏ ‎‡9 1‏
919 ‎‡a impactofcomorbidityonshorttermmortalityandoverallsurvivalofheadandneckcancerpatients‏ ‎‡A Impact of comorbidity on short-term mortality and overall survival of head and neck cancer patients‏ ‎‡9 1‏
919 ‎‡a imageguidedsurgeryinheadandneckcancercurrentpracticeandfuturedirectionsofopticalimaging‏ ‎‡A Image-guided surgery in head and neck cancer: current practice and future directions of optical imaging.‏ ‎‡9 1‏
919 ‎‡a fibroblastgrowthfactorreceptorsininvitroandinvivochondrogenesisrelatingtissueengineeringusingadultmesenchymalstemcellstoembryonicdevelopment‏ ‎‡A Fibroblast Growth Factor Receptors in In Vitro and In Vivo Chondrogenesis: Relating Tissue Engineering Using Adult Mesenchymal Stem Cells to Embryonic Development‏ ‎‡9 1‏
919 ‎‡a illnesscognitionsinheadandnecksquamouscellcarcinomapredictingqualityoflifeoutcome‏ ‎‡A Illness cognitions in head and neck squamous cell carcinoma: predicting quality of life outcome‏ ‎‡9 1‏
919 ‎‡a hypofractionatedradiotherapydenotedasthechristieschemeaneffectivemeansofpalliatingpatientswithheadandneckcancersnotsuitableforcurativetreatment‏ ‎‡A Hypofractionated radiotherapy denoted as the "Christie scheme": an effective means of palliating patients with head and neck cancers not suitable for curative treatment‏ ‎‡9 1‏
919 ‎‡a experienceofpalliativecareforpatientswithheadandneckcancerthroughtheeyesofnextofkinimpactofanexpertcenter‏ ‎‡A Experience of palliative care for patients with head and neck cancer through the eyes of next of kin: impact of an Expert Center‏ ‎‡9 1‏
919 ‎‡a evaluatingadherencetothedutchguidelinefordiagnosistreatmentandfollowupoflaryngealcarcinomas‏ ‎‡A Evaluating adherence to the Dutch guideline for diagnosis, treatment and follow-up of laryngeal carcinomas‏ ‎‡9 1‏
919 ‎‡a effectsoftransforminggrowthfactorβsubtypesoninvitrocartilageproductionandmineralizationofhumanbonemarrowstromalderivedmesenchymalstemcells‏ ‎‡A Effects of transforming growth factor-β subtypes on in vitro cartilage production and mineralization of human bone marrow stromal-derived mesenchymal stem cells‏ ‎‡9 1‏
919 ‎‡a dualwavelengthtumortargetingfordetectionofhypopharyngealcancerusingnearinfraredopticalimaginginananimalmodel‏ ‎‡A Dual wavelength tumor targeting for detection of hypopharyngeal cancer using near-infrared optical imaging in an animal model‏ ‎‡9 1‏
919 ‎‡a dnaploidystatusasaprognosticmarkerandpredictoroflymphnodemetastasisinlaryngealcarcinoma‏ ‎‡A DNA ploidy status as a prognostic marker and predictor of lymph node metastasis in laryngeal carcinoma‏ ‎‡9 1‏
919 ‎‡a discriminationbetweenoralcancerandhealthytissuebasedonwatercontentdeterminedbyramanspectroscopy‏ ‎‡A Discrimination between oral cancer and healthy tissue based on water content determined by Raman spectroscopy‏ ‎‡9 1‏
919 ‎‡a differencesincancergenecopynumberalterationsbetweenepsteinbarrviruspositiveandepsteinbarrvirusnegativenasopharyngealcarcinoma‏ ‎‡A Differences in cancer gene copy number alterations between Epstein-Barr virus-positive and Epstein-Barr virus-negative nasopharyngeal carcinoma‏ ‎‡9 1‏
919 ‎‡a detectionoforalsquamouscellcarcinomaandcervicallymphnodemetastasisusingactivatablenearinfraredfluorescenceagents‏ ‎‡A Detection of oral squamous cell carcinoma and cervical lymph node metastasis using activatable near-infrared fluorescence agents.‏ ‎‡9 1‏
919 ‎‡a cytologyandhistologyhavelimitedaddedvalueinprognosticmodelsforsalivaryglandcarcinomas‏ ‎‡A Cytology and histology have limited added value in prognostic models for salivary gland carcinomas‏ ‎‡9 1‏
919 ‎‡a conditionalrelativesurvivalinheadandnecksquamouscellcarcinomapermanentexcessmortalityriskforlongtermsurvivors‏ ‎‡A Conditional relative survival in head and neck squamous cell carcinoma: Permanent excess mortality risk for long-term survivors‏ ‎‡9 1‏
919 ‎‡a complianceandefficiencybeforeandafterimplementationofaclinicalpracticeguidelineforlaryngealcarcinomas‏ ‎‡A Compliance and efficiency before and after implementation of a clinical practice guideline for laryngeal carcinomas‏ ‎‡9 1‏
919 ‎‡a comorbidityasamajorriskfactorformortalityandcomplicationsinheadandnecksurgery‏ ‎‡A Comorbidity as a major risk factor for mortality and complications in head and neck surgery‏ ‎‡9 1‏
919 ‎‡a clinicaloutcomeoft1glotticcarcinomasincetheintroductionofendoscopicco2lasersurgeryastreatmentoption‏ ‎‡A Clinical outcome of T1 glottic carcinoma since the introduction of endoscopic CO2 laser surgery as treatment option‏ ‎‡9 1‏
919 ‎‡a cancerstemcellenrichmentmarkercd98aprognosticfactorforsurvivalinpatientswithhumanpapillomaviruspositiveoropharyngealcancer‏ ‎‡A Cancer stem cell enrichment marker CD98: a prognostic factor for survival in patients with human papillomavirus-positive oropharyngeal cancer‏ ‎‡9 1‏
919 ‎‡a absentandabundantmetimmunoreactivityisassociatedwithpoorprognosisofpatientswithoralandoropharyngealsquamouscellcarcinoma‏ ‎‡A Absent and abundant MET immunoreactivity is associated with poor prognosis of patients with oral and oropharyngeal squamous cell carcinoma‏ ‎‡9 1‏
919 ‎‡a beneficialtumormicroenvironmentinoropharyngealsquamouscellcarcinomaischaracterizedbyahightcellandlowil17+cellfrequency‏ ‎‡A A beneficial tumor microenvironment in oropharyngeal squamous cell carcinoma is characterized by a high T cell and low IL-17(+) cell frequency‏ ‎‡9 1‏
919 ‎‡a qualityoflifeandvoiceoutcomeofpatientstreatedwithtransoralcolasermicrosurgeryforearlyglotticcarcinomat1t2a2yearfollowupstudy‏ ‎‡A Quality of life and voice outcome of patients treated with transoral CO laser microsurgery for early glottic carcinoma (T1-T2): a 2-year follow-up study‏ ‎‡9 1‏
919 ‎‡a ramanspectroscopicanalysisofthemolecularcompositionoforalcavitysquamouscellcarcinomaandhealthytonguetissue‏ ‎‡A Raman spectroscopic analysis of the molecular composition of oral cavity squamous cell carcinoma and healthy tongue tissue‏ ‎‡9 1‏
919 ‎‡a resectionmarginsinoralcancersurgeryroomforimprovement‏ ‎‡A Resection margins in oral cancer surgery: Room for improvement.‏ ‎‡9 1‏
919 ‎‡a roleofepsteinbarrvirusdnameasurementinplasmaintheclinicalmanagementofnasopharyngealcarcinomainalowriskarea‏ ‎‡A Role of Epstein-Barr virus DNA measurement in plasma in the clinical management of nasopharyngeal carcinoma in a low risk area.‏ ‎‡9 1‏
919 ‎‡a 2malignantneoplasiainearly‏ ‎‡A Second malignant neoplasia in early‏ ‎‡9 1‏
919 ‎‡a 2malignantneoplasiainearlytist1glotticcarcinoma‏ ‎‡A Second malignant neoplasia in early (TIS-T1) glottic carcinoma‏ ‎‡9 1‏
919 ‎‡a survivalofpatientswithpalliativeheadandneckcancer‏ ‎‡A Survival of patients with palliative head and neck cancer.‏ ‎‡9 1‏
919 ‎‡a targetingintegrinsandenhancedpermeabilityandretention‏ ‎‡A Targeting integrins and enhanced permeability and retention‏ ‎‡9 1‏
919 ‎‡a targetingintegrinsandenhancedpermeabilityandretentionepreffectforopticalimagingoforalcancer‏ ‎‡A Targeting integrins and enhanced permeability and retention (EPR) effect for optical imaging of oral cancer‏ ‎‡9 1‏
919 ‎‡a ehealthselfmanagementapplicationoncokompasthatsupportscancersurvivorstoimprovehealthrelatedqualityoflifeandreducesymptomswhichgroupsbenefitmost‏ ‎‡A The eHealth self-management application 'Oncokompas' that supports cancer survivors to improve health-related quality of life and reduce symptoms: which groups benefit most?‏ ‎‡9 1‏
919 ‎‡a treatmentsandcostsforrecurrentandormetastaticsquamouscellcarcinomaoftheheadandneckinthenetherlands‏ ‎‡A Treatments and costs for recurrent and/or metastatic squamous cell carcinoma of the head and neck in the Netherlands‏ ‎‡9 1‏
919 ‎‡a updateandexternalvalidationofaheadandneckcancerprognosticmodel‏ ‎‡A Update and external validation of a head and neck cancer prognostic model‏ ‎‡9 1‏
919 ‎‡a utilityapproachtodecisionmakinginextendedt1andlimitedt2glotticcarcinoma‏ ‎‡A Utility approach to decision-making in extended T1 and limited T2 glottic carcinoma‏ ‎‡9 1‏
919 ‎‡a validationofageneexpressionsignatureforassessmentoflymphnodemetastasisinoralsquamouscellcarcinoma‏ ‎‡A Validation of a gene expression signature for assessment of lymph node metastasis in oral squamous cell carcinoma.‏ ‎‡9 1‏
919 ‎‡a variationinintegratedheadandneckcancercareimpactofpatientandhospitalcharacteristics‏ ‎‡A Variation in Integrated Head and Neck Cancer Care: Impact of Patient and Hospital Characteristics‏ ‎‡9 1‏
919 ‎‡a voiceoutcomeafterunilateralelstype3orbilateraltype2resectionsfort1t2glotticcarcinomaresultsafter1year‏ ‎‡A Voice outcome after unilateral ELS type III or bilateral type II resections for T1-T2 glottic carcinoma: Results after 1 year‏ ‎‡9 1‏
946 ‎‡a b‏ ‎‡9 1‏
996 ‎‡2 ISNI|0000000387777252‏
996 ‎‡2 ISNI|0000000024975006‏
996 ‎‡2 ISNI|0000000026543143‏
996 ‎‡2 NUKAT|n 2006082691‏
996 ‎‡2 ISNI|0000000460139880‏
996 ‎‡2 ISNI|0000000397022996‏
996 ‎‡2 NTA|155433024‏
996 ‎‡2 NTA|078340993‏
996 ‎‡2 ISNI|0000000388265101‏
996 ‎‡2 NTA|189652683‏
996 ‎‡2 LC|n 82083241‏
996 ‎‡2 NTA|241573866‏
996 ‎‡2 NTA|072304650‏
996 ‎‡2 NTA|075047519‏
996 ‎‡2 ISNI|0000000459077109‏
996 ‎‡2 ISNI|0000000017552128‏
996 ‎‡2 NTA|165893133‏
996 ‎‡2 NTA|239328051‏
996 ‎‡2 LC|no2017081831‏
996 ‎‡2 ISNI|0000000351479683‏
996 ‎‡2 ISNI|0000000387225706‏
996 ‎‡2 DNB|1124557962‏
996 ‎‡2 NTA|16062844X‏
996 ‎‡2 ISNI|000000039642343X‏
996 ‎‡2 J9U|987007516714705171‏
996 ‎‡2 ISNI|0000000443206279‏
996 ‎‡2 NTA|072893508‏
996 ‎‡2 NTA|069745706‏
996 ‎‡2 ISNI|0000000039328573‏
996 ‎‡2 DNB|170952150‏
996 ‎‡2 NTA|42637715X‏
996 ‎‡2 NTA|14770975X‏
996 ‎‡2 DNB|107371831X‏
996 ‎‡2 ISNI|0000000108003765‏
996 ‎‡2 NTA|16059362X‏
996 ‎‡2 BNF|15048569‏
996 ‎‡2 NTA|351240659‏
996 ‎‡2 NTA|074801279‏
996 ‎‡2 NTA|104705663‏
996 ‎‡2 ISNI|0000000393599501‏
996 ‎‡2 NTA|410849073‏
996 ‎‡2 NTA|392860376‏
996 ‎‡2 ISNI|0000000389957134‏
996 ‎‡2 ISNI|0000000389517665‏
996 ‎‡2 ISNI|0000000388053416‏
996 ‎‡2 ISNI|000000046003013X‏
996 ‎‡2 ISNI|0000000389328098‏
996 ‎‡2 ISNI|0000000390471684‏
996 ‎‡2 NTA|073053287‏
996 ‎‡2 ISNI|0000000394426127‏
996 ‎‡2 DNB|1065851715‏
996 ‎‡2 LC|n 83239392‏
996 ‎‡2 ISNI|0000000356734647‏
996 ‎‡2 NTA|37614436X‏
996 ‎‡2 NTA|142733431‏
996 ‎‡2 NTA|152457747‏
996 ‎‡2 NTA|382710525‏
996 ‎‡2 ISNI|0000000395651908‏
996 ‎‡2 LC|no2013003158‏
996 ‎‡2 LC|n 90656819‏
996 ‎‡2 ISNI|0000000031588004‏
996 ‎‡2 NTA|243907656‏
996 ‎‡2 ISNI|0000000389464815‏
996 ‎‡2 CAOONL|ncf11233842‏
996 ‎‡2 ISNI|0000000394952290‏
996 ‎‡2 NTA|071049061‏
996 ‎‡2 ISNI|0000000387319411‏
996 ‎‡2 ISNI|0000000394294259‏
996 ‎‡2 NTA|072419067‏
996 ‎‡2 NTA|432158529‏
996 ‎‡2 NTA|270896767‏
996 ‎‡2 PLWABN|9812169693205606‏
996 ‎‡2 NTA|153330910‏
996 ‎‡2 ISNI|0000000392016431‏
996 ‎‡2 NTA|421344040‏
996 ‎‡2 NTA|296149195‏
996 ‎‡2 NTA|35381914X‏
996 ‎‡2 NTA|325851638‏
996 ‎‡2 NTA|152139192‏
996 ‎‡2 ISNI|0000000392553966‏
996 ‎‡2 NTA|273430823‏
996 ‎‡2 ISNI|0000000463602412‏
996 ‎‡2 LC|n 83072612‏
996 ‎‡2 LC|no2001050043‏
996 ‎‡2 NTA|075234459‏
996 ‎‡2 BIBSYS|90509269‏
996 ‎‡2 NTA|291006167‏
996 ‎‡2 NTA|112124720‏
996 ‎‡2 PLWABN|9810606019805606‏
996 ‎‡2 ISNI|0000000102252648‏
996 ‎‡2 NTA|425784126‏
996 ‎‡2 NTA|071845526‏
996 ‎‡2 ISNI|0000000392960211‏
996 ‎‡2 NUKAT|n 2015093881‏
996 ‎‡2 CAOONL|ncf10385344‏
996 ‎‡2 ISNI|0000000387570585‏
996 ‎‡2 DNB|1056128682‏
996 ‎‡2 NTA|434760005‏
996 ‎‡2 NTA|072584165‏
996 ‎‡2 CAOONL|ncf11425932‏
996 ‎‡2 NTA|074092294‏
996 ‎‡2 NTA|243976402‏
996 ‎‡2 ISNI|0000000396347537‏
996 ‎‡2 NTA|069464170‏
996 ‎‡2 NTA|069592349‏
996 ‎‡2 DNB|173794637‏
996 ‎‡2 DNB|1156759722‏
996 ‎‡2 ISNI|0000000023762543‏
996 ‎‡2 LC|n 95105520‏
996 ‎‡2 ISNI|0000000117054986‏
996 ‎‡2 ISNI|0000000396134347‏
996 ‎‡2 LC|no2001067216‏
996 ‎‡2 NTA|240116429‏
996 ‎‡2 ISNI|0000000052440180‏
996 ‎‡2 SUDOC|166980463‏
996 ‎‡2 NII|DA16098343‏
996 ‎‡2 NTA|314631836‏
996 ‎‡2 ISNI|0000000387103899‏
996 ‎‡2 NTA|409162078‏
996 ‎‡2 ISNI|0000000042984475‏
996 ‎‡2 NTA|073985481‏
996 ‎‡2 LC|no2020122097‏
996 ‎‡2 ISNI|0000000384072441‏
996 ‎‡2 ISNI|0000000022307717‏
996 ‎‡2 NTA|070329265‏
996 ‎‡2 LC|n 94043907‏
996 ‎‡2 NTA|343386526‏
996 ‎‡2 NTA|163620598‏
996 ‎‡2 NTA|337806438‏
996 ‎‡2 NTA|14876200X‏
996 ‎‡2 NTA|298803518‏
996 ‎‡2 NTA|071805648‏
996 ‎‡2 ISNI|0000000393456690‏
996 ‎‡2 NTA|391782304‏
996 ‎‡2 ISNI|0000000391657595‏
996 ‎‡2 NTA|30482304X‏
996 ‎‡2 NTA|071480889‏
996 ‎‡2 DNB|1158725566‏
996 ‎‡2 ISNI|000000003939954X‏
996 ‎‡2 BIBSYS|6053141‏
996 ‎‡2 NUKAT|n 2004045455‏
996 ‎‡2 ISNI|0000000388813833‏
996 ‎‡2 ISNI|0000000394185861‏
996 ‎‡2 ISNI|0000000114355177‏
996 ‎‡2 NTA|401642712‏
996 ‎‡2 NTA|068078781‏
996 ‎‡2 ISNI|0000000395475545‏
996 ‎‡2 NTA|172378621‏
996 ‎‡2 BIBSYS|6090559‏
996 ‎‡2 NUKAT|n 99092172‏
996 ‎‡2 ISNI|000000039139094X‏
996 ‎‡2 ISNI|0000000388827055‏
996 ‎‡2 ISNI|0000000101135060‏
996 ‎‡2 NTA|070148287‏
996 ‎‡2 ISNI|0000000058870341‏
996 ‎‡2 ISNI|0000000483081220‏
996 ‎‡2 ISNI|0000000390667089‏
996 ‎‡2 ISNI|0000000388675565‏
996 ‎‡2 NTA|069746915‏
996 ‎‡2 ISNI|000000039692826X‏
996 ‎‡2 NTA|067538045‏
996 ‎‡2 NTA|334627583‏
996 ‎‡2 ISNI|000000039575208X‏
996 ‎‡2 BIBSYS|90306713‏
996 ‎‡2 DNB|1028333870‏
996 ‎‡2 NTA|402378903‏
996 ‎‡2 NTA|357086074‏
996 ‎‡2 BIBSYS|90933094‏
996 ‎‡2 NTA|370697316‏
996 ‎‡2 NTA|069182124‏
996 ‎‡2 NTA|143931547‏
996 ‎‡2 ISNI|0000000034282924‏
996 ‎‡2 ISNI|0000000391844008‏
996 ‎‡2 NTA|239398335‏
996 ‎‡2 ISNI|0000000394595537‏
996 ‎‡2 LC|n 2014038317‏
996 ‎‡2 SUDOC|255403682‏
996 ‎‡2 NTA|43866079X‏
996 ‎‡2 NTA|24001863X‏
996 ‎‡2 ISNI|0000000389514923‏
996 ‎‡2 ISNI|0000000389960368‏
996 ‎‡2 NTA|343558653‏
996 ‎‡2 NTA|323263526‏
996 ‎‡2 NTA|074297953‏
996 ‎‡2 NTA|343195712‏
996 ‎‡2 ISNI|0000000388996377‏
996 ‎‡2 LIH|LNB:_s_D_z_;=CB‏
996 ‎‡2 ISNI|0000000434950688‏
996 ‎‡2 ISNI|0000000392142227‏
996 ‎‡2 NTA|06837724X‏
996 ‎‡2 PLWABN|9812831261205606‏
996 ‎‡2 ISNI|0000000080007253‏
996 ‎‡2 NTA|19500048X‏
996 ‎‡2 NTA|074894420‏
996 ‎‡2 NUKAT|n 2012167426‏
996 ‎‡2 NTA|417257899‏
996 ‎‡2 NUKAT|n 2018043247‏
996 ‎‡2 PLWABN|9810692936305606‏
996 ‎‡2 ISNI|0000000016950060‏
996 ‎‡2 ISNI|0000000043616068‏
996 ‎‡2 ISNI|0000000387172667‏
996 ‎‡2 NUKAT|n 2017168336‏
996 ‎‡2 RERO|A006160855‏
996 ‎‡2 LC|no 88002093‏
996 ‎‡2 NTA|298198800‏
996 ‎‡2 NTA|158554450‏
996 ‎‡2 NTA|421494042‏
996 ‎‡2 ISNI|0000000116793365‏
996 ‎‡2 ISNI|0000000393463495‏
996 ‎‡2 NTA|180735616‏
996 ‎‡2 ISNI|0000000394062079‏
996 ‎‡2 ISNI|0000000390439801‏
996 ‎‡2 SUDOC|19628645X‏
996 ‎‡2 SUDOC|165130342‏
996 ‎‡2 NTA|07483536X‏
996 ‎‡2 J9U|987007348587105171‏
996 ‎‡2 NTA|435090488‏
996 ‎‡2 JPG|500529988‏
996 ‎‡2 ISNI|0000000395171066‏
996 ‎‡2 ISNI|0000000085428807‏
996 ‎‡2 NTA|14691497X‏
996 ‎‡2 ISNI|0000000389873766‏
996 ‎‡2 NTA|071201572‏
996 ‎‡2 ISNI|000000039120166X‏
996 ‎‡2 ISNI|0000000080038586‏
996 ‎‡2 NTA|351235728‏
996 ‎‡2 LC|n 78023115‏
996 ‎‡2 LC|n 99028076‏
996 ‎‡2 NTA|380241080‏
996 ‎‡2 NTA|262879239‏
996 ‎‡2 ISNI|0000000390572047‏
996 ‎‡2 NTA|067536409‏
996 ‎‡2 NTA|074061089‏
996 ‎‡2 LC|no2010133500‏
996 ‎‡2 NII|DA08828203‏
996 ‎‡2 NTA|08645949X‏
996 ‎‡2 ISNI|0000000074063558‏
996 ‎‡2 SUDOC|119253348‏
996 ‎‡2 NTA|363565574‏
996 ‎‡2 NTA|073655643‏
996 ‎‡2 NTA|073153745‏
996 ‎‡2 NTA|175751854‏
996 ‎‡2 ISNI|0000000387487212‏
996 ‎‡2 NTA|325846790‏
997 ‎‡a 0 0 lived 0 0‏ ‎‡9 1‏